Acyl-coa dehydrogenase, short-chain, deficiency of

Overview

What is Short chain acyl-CoA dehydrogenase deficiency (SCADD)?

Short chain acyl-CoA dehydrogenase deficiency, or SCADD, is a genetic disease in which the body is not able to properly break down fat to create energy. SCADD is one of a group of disorders called fatty acid oxidation disorders. The body usually gets its energy by breaking down (sometimes called "burning") sugars and fats. People with SCADD are able to break down sugar normally but, because of a problem in the gene called ACADS they are not able to break down a type of fat called short chain fatty acids.

Most people who have SCADD do not have any symptoms. At this time (2016), researchers do not understand why some people with SCADD have symptoms and others do not. For people with SCADD who do have symptoms, these symptoms include problems eating, low muscle tone (they may be floppy), delays in development, vomiting, low energy (lethargy) and seizures in infants and muscle cramps or pain and difficulty with exercise or episodes of nausea, vomiting and shortness of breath in older children and adults.

When a person with SCADD is healthy and eating regularly, they are able to get enough energy from the sugars in their diet and they appear totally healthy. However, when certain people with SCADD go a long time without eating and their bodies begin to burn fat for energy, they can become sick with a metabolic crisis, which can cause excessive sleepiness or irritability, vomiting or diarrhea, and increased levels of acids in the blood (metabolic acidosis). If a metabolic crisis is not treated, the child may have seizures, problems breathing, or coma. Common reasons for going without food include illness, operations, or when babies begin to sleep through the night.

References
Show More Content Like This

More Overview Content

Are there other names for Short chain acyl-CoA dehydrogenase deficiency (SCADD)?

How common is Short chain acyl-CoA dehydrogenase deficiency (SCADD)?

Are there different forms of Short chain acyl-CoA dehydrogenase deficiency (SCADD)?

Are there other names for Short chain acyl-CoA dehydrogenase deficiency (SCADD)?

Other names for Short-Chain Acyl-Coenzyme A Dehydrogenase Deficiency include:

  • SCADD, (pronounced S-cad)
  • SCAD deficiency, (pronounced S-cad deficiency)
  • Short-chain acyl-CoA deficiency
  • Short chain acyl-CoA dehydrogenase deficiency
  • Acyl-CoA dehydrogenase short chain (ACADS) deficiency
  • Deficiency of butyryl-CoA dehydrogenase

SCADD belongs to a category of diseases called "Fatty Acid Oxidation Disorders" in which the body is not able to properly break down fats for energy.

References
How common is Short chain acyl-CoA dehydrogenase deficiency (SCADD)?

The genetic mutations that cause SCADD are estimated to occur in between 1 in 35,000 to 1 in 85,000 people.

Most people diagnosed with SCADD never develop symptoms.

References
Are there different forms of Short chain acyl-CoA dehydrogenase deficiency (SCADD)?

SCADD affects people differently. Most children and adults with SCADD never have any symptoms.

Others have very mild symptoms or only develop symptoms when they have another condition that puts extra stress on their bodies.

Some infants and children with SCADD have serious symptoms such as growth and developmental delays, low blood sugar, and seizures.

Another form of SCADD is only found in adults. The adult form of SCADD mainly affects the muscles. It can cause muscle pain and weakness. Adults with SCADD may also have nausea, vomiting, and shortness of breath. The muscle problems often get worse after strenuous exercise.

Everyone with SCADD has mutations (changes) in the same gene. The gene is called ACADS. This gene provides the instructions for making the enzyme, or protein, called "short acyl-coenzyme A dehydrogenase," or "SCAD" which breaks down fat for energy. Different mutations in the gene cause different problems in the enzyme. Some mutations stop the enzyme from working at all and others just slow it down. The different types of SCADD can by partially explained by the different types of mutations since people with mutations that just slow the enzyme down are still able to break down some short chain fats while people with mutations that stop the enzyme from working at all are not able to to break down any. But there seem to be other factors, perhaps other genes or other illnesses, that also affect whether a person with SCADD will show symptoms. Researchers are working to understand these differences better.

References

We use cookies to ensure that we give you the best experience on our website. By continuing to browse this site, you are agreeing to our use of cookies.

Continue Find out more about our use of cookies and similar technology

This content comes from a hidden element on this page.

The inline option preserves bound JavaScript events and changes, and it puts the content back where it came from when it is closed.

Remember Me